Isradipine controlled release tablet and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- DEZHOU DEYAO PHARMA
- Publication Date
- 2019-10-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical preparations, in particular to a single-chamber double-layer osmotic pump-type controlled-release preparation containing the active drug isradipine and a preparation method thereof, which enables isradipine to release the drug at a controlled rate in the gastrointestinal tract, Realize stable blood drug concentration in the body and improve clinical treatment effect. Background technique
[0002] Isradipine (also known as: Isradipine), chemical name: isopropylmethyl (±)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl -3,6-Pyridinedicarboxylate. Isradipine is a new type of dihydropyridine calcium channel blocker, like other dihydropyridine drugs, by blocking the influx of transmembrane calcium ions, it can effectively and selectively inhibit the contraction caused by depolarization in the It plays a role in cardiac muscle and vascular smooth muscle, has high selectivity of blood vessels, and can relax...